Journals in General microbiology

Acta Tropica

ISSN: 0001-706X
5 Year impact factor: 2.4
Impact factor: 2.1

Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contributions may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:• Out of scope.• Manuscripts of minimal international relevance, including regional reports and studies of local interest.• Case reports.• Parasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is required.• Field studies not replicated at least over two years. • Studies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.• Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:• Matches the scientific scope of the journal,• Follows the instructions specified in Acta Tropica guide for authors,• Presents results that significantly advance science including innovative new approaches,• Meets quality standards of presentation and literature citation,• Demonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

American Journal of Infection Control

ISSN: 0196-6553
5 Year impact factor: 3.1
Impact factor: 3.8

The Official Publication of the Association for Professionals in Infection Control and Epidemiology, Inc.AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. AJIC is included in Index Medicus and CINAHL.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Anaerobe

ISSN: 1075-9964
5 Year impact factor: 2.6
Impact factor: 2.5

Anaerobe is essential reading for those who wish to remain at the forefront of discoveries relating to life processes of strict anaerobes. The journal is multi-disciplinary, and provides a unique forum for those investigating strictly anaerobic organisms that cause infections in humans and animals, as well as anaerobes that play roles in microbiomes or environmental processes. Anaerobe will consider manuscripts on anaerobic bacteria, archaea, fungi, protists as well as bacteriophages of anaerobes.Relevant topics fall into the broad categories of:Anaerobes in human and animal diseasesAnaerobes in the microbiomeAnaerobes in the environmentAnaerobes in industrial processes (including biofuels and waste management)Microbial ecology of anaerobesClinical microbiology involving anaerobesPathogenesis of anaerobic organisms (including their toxins)Molecular biology and genetics of anaerobesTaxonomy of anaerobesPhysiology of anaerobesPapers describing innovative methodologies, technologies and applications to investigate anaerobic microorganisms are also of interest. Manuscripts describing novel species of obligate anaerobes will be reviewed, if the description of the new species also includes information showing novel phenotypic characteristics, pathogenicity and/or unique metabolic activity within the microbiome from which it was isolated. Manuscripts describing novel anaerobic species that are only different from other related members of a genus based on genotype will not be reviewed.Manuscript types accepted (see Guide for Authors for more information):Original research articles Original research reports on one or more of the above listed categories. Up to 4000 words, not including a structured abstract, figures, tables and references.Short Communications Presentation of brief observations that do not warrant a full-length publication. Up to 1500 words not including abstract, figures, tables and references. Short communications should report complete datasets and not preliminary findings.Reviews and minireviews Reviews are typically 7,000 words in length including relevant tables and/or figures. Mini-reviews are typically restricted to 2,500 words in length.*New from March 1st 2023: Anaerobe no longer accepts unsolicited reviews and standalone mini-reviews. Proposals for reviews and mini-reviews within the topics mentioned above are welcome for consideration by the journal. Please provide a proposed title and detailed outline of the topic to be covered to an editor-in-chief by email.Case reports Presentation of a short report on a significant clinical observation, preceded by a minireview (up to 2500 words) of the literature describing the background of similar cases/infections, what is known about the associated microbe, and other clinically relevant information. *New from March 2023: Case Reports will only be considered in this new format.Commentaries Occasionally, Anaerobe will consider publication of commentaries on important new work in the field. Such commentaries will be invited by the editors-in-chief. Suggestions for commentaries may be emailed to an Editor-in-Chief. Unsolicited commentaries will not be considered.Please note:1. Anaerobe does not accept manuscripts on descriptive, sequence-based surveys of microbiomes, even if the environments of the sampled ecosystems select for anaerobic species. However, when studies such as these are accompanied by direct, mechanistic assays of strictly anaerobic components, they will be considered for publication. 2. Anaerobe will not consider manuscripts that deal only with descriptive accounts of the beneficial effects of potentially novel probiotic strains, unless such strains belong to strictly anaerobic species that have previously not been associated with probiotic features. Anaerobe will continue to consider manuscripts for publication that address determinations of the specific mechanism(s) of action of anaerobic probiotic strains.

Subscriptions

Antiviral Research

ISSN: 0166-3542
5 Year impact factor: 5
Impact factor: 4.5

Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identification and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses;assessments of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.

Subscriptions

Atherosclerosis Plus

ISSN: 1567-5688
5 Year impact factor: 1.4
Impact factor: 1.4

Previously published as Atherosclerosis Supplements .Atherosclerosis Plus is supported by the European Atherosclerosis Society.Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions. Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. Finally, the journal periodically publishes special theme issues devoted to areas of current interest.

Subscriptions

Biologicals

ISSN: 1045-1056
5 Year impact factor: 1.6
Impact factor: 1.5

Official Journal of the International Alliance for Biological StandardizationBiologicals provides a modern and multidisciplinary international forum for the publication of research that advances the development, manufacturing, quality control, standardization, safety, efficacy, and regulatory aspects of human and veterinary biological products derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern. Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas IncludeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines • Blood products • Cell biology • Cell culture technology • Cellular immunology • Cytokines and allied mediators • Diagnostics • Downstream processing • Gene transfer and expression • General bacteriology • General virology, endogenous and adventitious viruses • Hormones • Immunochemistry • Molecular biology • Monoclonal antibodies • Parasitology • Prion and prion disease • Protein chemistry • Toxins • Toxoids • Viral vaccines

Subscriptions

Cell

ISSN: 0092-8674
5 Year impact factor: 49
Impact factor: 45.5

Cell publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The basic criterion for considering papers is whether the results provide significant conceptual advances into, or raise provocative questions and hypotheses regarding, an interesting and important biological question. In addition to primary research articles in four formats, Cell features review and opinion articles on recent research advances and issues of interest to its broad readership in the leading edge section.Visit the Cell Press website for more information about Cell - http://www.cell.com/cell/home

Subscriptions

Clinical Microbiology Newsletter

ISSN: 0196-4399

Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.

Subscriptions

Clinical Microbiology and Infection

ISSN: 1198-743X
5 Year impact factor: 9.3
Impact factor: 10.9

Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology as related to these fields.

Subscriptions

Comparative Immunology, Microbiology & Infectious Diseases

ISSN: 0147-9571
5 Year impact factor: 2.2
Impact factor: 2

An International Journal focused on Comparative Veterinary and Medical ResearchComparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine - One Health" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .CIMID is mainly focusing on applied veterinary medicine with a particular focus on zoonotic pathogens. It includes etiology, biology, clinical diseases, epidemiology, diagnosis, control. Experimental in vitro studies and studies on laboratory animals are generally not accepted. Non infectious diseases are not accepted. Specific focus on human diseases can only be accepted if it concerns major zoonotic pathogens. Reviews are generally not accepted, except if they contain new or recent developments. CIMID does not accept manuscript focusing on Mycology.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial and parasitic diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals and/or can serve as a model for human diseases). Papers dealing primarily with epidemiology will be considered if they demonstrate a clear impact on the clinical features, pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, parasitology, immunology or pathogenesis must address issues of comparative medical interest. Manuscripts focusing on probiotics or diseases and/or immunology of fishes are not part of our overall scope, as they are better fitted to more specialized journals. Manuscripts dealing with food hygiene and food risk are not part of our overall scope. Manuscripts dealing strictly with experimental design and fundamental research may not be considered depending the overall consequences for the knowledge of a disease.Review articles can be accepted. They should focus either on a pathogen or on analyses of the mechanisms of host-pathogen interactions including epidemiological studies. Proposal for such manuscripts should be submitted to the Co-Editors in Chief for approval before submitting the manuscript.Papers focusing solely on diagnostic techniques, case reports or drug trials will generally not be accepted. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).Instruction for Authors:Comparative Immunology, Microbiology & Infectious Diseases consists of six issues a year and publishes original papers or reviews of the status of current research relative to the different fields of Immunology, Microbiology and Infectious Diseases of animals with a possible impact on human health.Immunology: manuscripts are accepted relative to the various branches of this discipline: fundamental Immunology, experimental or comparative Immunology, clinical Immunology, Immunopathology.Microbiology: manuscripts are accepted relative to the various branches of this discipline: Virology, Bacteriology, Parasitology.Infectious Diseases: manuscripts are accepted relative to the various branches: Etiology, Pathogenesis, Diagnosis, Prophylaxis, Treatment, Epidemiology, Epizootiology of infectious diseases of animals with a particular interest on zoonoses and one health.

Subscriptions

Related subjects

Applied microbiology

Biodeterioration biodegradation and bioremediation

Clinical microbiology

Diagnostic microbiology

Infectious diseases and chemotherapy

Microbial functional genomics

Microbiological methodology

Molecular microbiology

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in General microbiology

Acta Tropica

American Journal of Infection Control

Anaerobe

Antiviral Research

Atherosclerosis Plus

Biologicals

Cell

Clinical Microbiology Newsletter

Clinical Microbiology and Infection

Comparative Immunology, Microbiology & Infectious Diseases

Related subjects